Article
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19.
Frontiers in immunology - 1 Jan 2025
Tokhanbigli Samaneh, Salami Ghaleh Samira, Rahimian Karim, Mahmanzar Mohammadamin, Bayat Saleha, Ahangarzadeh Shahrzad, Moradi Bahman, Mahmanzar Reza, Wang Yunliang, Oliver Brian Gregory George, Deng Youping
Abstract excerpt
In line with encountering the world with the emergence of vaccine-resistance variants of SARS-CoV-2, 15,669,529 samples that received COVID-19 vaccines until April 2023 were investigated as two doses in the first phase and booster vaccinations in the second phase. The analysis shows that D614G and P681 mutations occurred in both phases. The E484 and Y655 mutations significantly emerged during the second phase....
Read the complete abstract on PubMedTopics
- SARS-CoV-2
- Humans
- COVID-19
- COVID-19 Vaccines
- Spike Glycoprotein, Coronavirus
- Mutation
